Johnson & Johnson (JNJ) Income from Continuing Operations (2009 - 2026)
Johnson & Johnson (JNJ) recorded Income from Continuing Operations of $5.53 billion in Q2 2026, down 0.1% from $5.54 billion a year earlier but up 5.7% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Income from Continuing Operations (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's Income from Continuing Operations came in at $21.04 billion as of Jun 28, 2026, down 7.2% year-over-year; for FY2025, it was $26.8 billion, up 90.6% from FY2024.
- Annual Income from Continuing Operations has a four-year compound annual growth rate of 16.2% (FY2021 to FY2025).
- Across earlier years, Income from Continuing Operations came in at $14.07 billion in FY2024 (+5.6%), $13.33 billion in FY2023 (-18.6%), $16.37 billion in FY2022 and $14.71 billion in FY2021.
- Quarterly Income from Continuing Operations has ranged from -$491 million in Q1 2023 to $11 billion in Q1 2025 over the past five years.
- On a year-over-year basis, Income from Continuing Operations rose in four of the last eight quarters, with growth averaging 36.2%.
- Peak year-over-year performance for Income from Continuing Operations in the last five years was growth of 237.9% in Q1 2025, against a decline of 52.4% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.24 billion (Q1 2026), $5.12 billion (Q4 2025) and $5.15 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 5.53 Bn |
| Mar 29, 2026 | 5.24 Bn |
| Dec 28, 2025 | 5.12 Bn |
| Sep 28, 2025 | 5.15 Bn |
| Jun 29, 2025 | 5.54 Bn |
| Mar 30, 2025 | 11.00 Bn |
| Dec 29, 2024 | 3.43 Bn |
| Sep 29, 2024 | 2.69 Bn |
| Jun 30, 2024 | 4.69 Bn |
| Mar 31, 2024 | 3.26 Bn |
| Dec 31, 2023 | 4.13 Bn |
| Oct 1, 2023 | 4.31 Bn |
| Jul 2, 2023 | 5.38 Bn |
| Apr 2, 2023 | -491.00 Mn |
| Jan 1, 2023 | 3.23 Bn |
| Oct 2, 2022 | 4.31 Bn |
| Jul 3, 2022 | 4.26 Bn |
| Apr 3, 2022 | 4.57 Bn |
| Oct 3, 2021 | 3.67 Bn |
| Jul 4, 2021 | 6.28 Bn |
API Access
Johnson & Johnson Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();